Zacks Research Forecasts Amdocs’ Q2 Earnings (NASDAQ:DOX)

Amdocs Limited (NASDAQ:DOX) – Equities researchers at Zacks Research cut their Q2 2026 EPS estimates for shares of Amdocs in a research note issued to investors on Tuesday, February 24th. Zacks Research analyst Team now forecasts that the technology company will earn $1.50 per share for the quarter, down from their previous forecast of $1.60. The consensus estimate for Amdocs’ current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs’ Q3 2026 earnings at $1.68 EPS, Q4 2026 earnings at $1.77 EPS, FY2026 earnings at $6.56 EPS, Q1 2027 earnings at $1.69 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.79 EPS, Q4 2027 earnings at $1.83 EPS and FY2027 earnings at $7.04 EPS.

A number of other analysts have also recently issued reports on the stock. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Bank of America cut their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Finally, Barclays lowered their price objective on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $92.33.

Amdocs Stock Performance

NASDAQ:DOX opened at $69.80 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a 50-day simple moving average of $77.63 and a two-hundred day simple moving average of $80.53. The firm has a market capitalization of $7.53 billion, a PE ratio of 13.50, a P/E/G ratio of 1.23 and a beta of 0.40. Amdocs has a 52-week low of $65.74 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period in the previous year, the business posted $1.66 earnings per share. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS.

Hedge Funds Weigh In On Amdocs

A number of institutional investors and hedge funds have recently modified their holdings of DOX. Pzena Investment Management LLC lifted its position in Amdocs by 82.6% in the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after buying an additional 5,443,766 shares during the last quarter. LSV Asset Management raised its stake in shares of Amdocs by 0.8% in the fourth quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock valued at $296,159,000 after acquiring an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Amdocs by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after acquiring an additional 54,676 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after purchasing an additional 91,900 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Amdocs by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after purchasing an additional 9,207 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.3%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is currently 40.81%.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs announced a multi‑year strategic collaboration with Amazon Web Services to combine Amdocs’ aOS agentic operating system with AWS AI and cloud capabilities to drive telecom modernization — a material commercial & product endorsement that supports future revenue growth. MWC 2026: Amdocs and AWS Announce Multi-Year Strategic Collaboration to Accelerate AI-Driven Telecom Modernization
• Positive Sentiment: Amdocs announced a collaboration with Microsoft to deliver AI‑accelerated application modernization (Amdocs Agentic Services + Microsoft AI), which can expand enterprise services and upsell opportunities. MWC 2026: Amdocs Collaborates with Microsoft to Bring AI-Accelerated Application Modernization to Enterprises
• Positive Sentiment: Amdocs partnered with Google Cloud to combine Gemini Enterprise CX with Amdocs’ Cognitive Core to create an agentic telco contact center — another strategic cloud/A.I. endorsement that could help win telco transformation deals. MWC 2026: Amdocs Collaborates with Google Cloud to Accelerate AI Adoption and Power the Agentic Telco Contact Center
• Positive Sentiment: Zacks Research raised multiple near‑ and medium‑term EPS forecasts (including FY2026/FY2027/FY2028 upgrades and several quarterly raises), which supports a more constructive earnings outlook and could underpin valuation. See Zacks coverage for context. Amdocs (DOX) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Published short‑interest notices show zero reported short interest and anomalous “NaN” increases across several February reporting dates — this appears to be a data/reporting issue and implies no visible short‑squeeze pressure at present.
• Negative Sentiment: Zacks trimmed its Q2 2026 EPS estimate from $1.60 to $1.50 in the same round of updates — a modest near‑term earnings downgrade that could temper sentiment around the next quarter.
• Negative Sentiment: Technically, the share price is below both the 50‑day and 200‑day moving averages noted in recent quotes, which can invite short‑term selling/ profit‑taking even amid positive fundamental headlines.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.